1134 related articles for article (PubMed ID: 11344187)
21. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
Bajaj M; Suraamornkul S; Piper P; Hardies LJ; Glass L; Cersosimo E; Pratipanawatr T; Miyazaki Y; DeFronzo RA
J Clin Endocrinol Metab; 2004 Jan; 89(1):200-6. PubMed ID: 14715850
[TBL] [Abstract][Full Text] [Related]
22. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.
Putz DM; Goldner WS; Bar RS; Haynes WG; Sivitz WI
Metabolism; 2004 Nov; 53(11):1454-61. PubMed ID: 15536601
[TBL] [Abstract][Full Text] [Related]
24. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians.
Lillioja S; Nyomba BL; Saad MF; Ferraro R; Castillo C; Bennett PH; Bogardus C
J Clin Endocrinol Metab; 1991 Oct; 73(4):866-76. PubMed ID: 1890157
[TBL] [Abstract][Full Text] [Related]
25. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
Osei K; Gaillard T; Schuster D
Obes Res; 2005 Jan; 13(1):179-85. PubMed ID: 15761178
[TBL] [Abstract][Full Text] [Related]
26. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
27. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
28. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.
Hotta K; Funahashi T; Bodkin NL; Ortmeyer HK; Arita Y; Hansen BC; Matsuzawa Y
Diabetes; 2001 May; 50(5):1126-33. PubMed ID: 11334417
[TBL] [Abstract][Full Text] [Related]
29. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
[TBL] [Abstract][Full Text] [Related]
30. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.
Weyer C; Hanson RL; Tataranni PA; Bogardus C; Pratley RE
Diabetes; 2000 Dec; 49(12):2094-101. PubMed ID: 11118012
[TBL] [Abstract][Full Text] [Related]
31. The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.
Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
Eur J Endocrinol; 2004 May; 150(5):715-8. PubMed ID: 15132729
[TBL] [Abstract][Full Text] [Related]
32. Exaggerated insulin secretion in Pima Indians and African-Americans but higher insulin resistance in Pima Indians compared to African-Americans and Caucasians.
Stefan N; Stumvoll M; Weyer C; Bogardus C; Tataranni PA; Pratley RE
Diabet Med; 2004 Oct; 21(10):1090-5. PubMed ID: 15384955
[TBL] [Abstract][Full Text] [Related]
33. Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates.
Pannacciulli N; Bunt JC; Ortega E; Funahashi T; Salbe AD; Bogardus C; Krakoff J
J Clin Endocrinol Metab; 2006 Apr; 91(4):1600-3. PubMed ID: 16449334
[TBL] [Abstract][Full Text] [Related]
34. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Vozarova B; Stefan N; Lindsay RS; Saremi A; Pratley RE; Bogardus C; Tataranni PA
Diabetes; 2002 Jun; 51(6):1889-95. PubMed ID: 12031978
[TBL] [Abstract][Full Text] [Related]
35. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus.
Winzer C; Wagner O; Festa A; Schneider B; Roden M; Bancher-Todesca D; Pacini G; Funahashi T; Kautzky-Willer A
Diabetes Care; 2004 Jul; 27(7):1721-7. PubMed ID: 15220253
[TBL] [Abstract][Full Text] [Related]
36. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
37. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
[TBL] [Abstract][Full Text] [Related]
38. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.
Stefan N; Kovacs P; Stumvoll M; Hanson RL; Lehn-Stefan A; Permana PA; Baier LJ; Tataranni PA; Silver K; Bogardus C
Diabetes; 2003 Jun; 52(6):1544-50. PubMed ID: 12765968
[TBL] [Abstract][Full Text] [Related]
39. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
Diabetes; 1990 Nov; 39(11):1430-5. PubMed ID: 2227116
[TBL] [Abstract][Full Text] [Related]
40. Low plasma adiponectin concentrations do not predict weight gain in humans.
Vozarova B; Stefan N; Lindsay RS; Krakoff J; Knowler WC; Funahashi T; Matsuzawa Y; Stumvoll M; Weyer C; Tataranni PA
Diabetes; 2002 Oct; 51(10):2964-7. PubMed ID: 12351434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
